1. Home
  2. SEPN vs LEGH Comparison

SEPN vs LEGH Comparison

Compare SEPN & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • LEGH
  • Stock Information
  • Founded
  • SEPN 2022
  • LEGH 2005
  • Country
  • SEPN United States
  • LEGH United States
  • Employees
  • SEPN N/A
  • LEGH N/A
  • Industry
  • SEPN
  • LEGH Homebuilding
  • Sector
  • SEPN
  • LEGH Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • LEGH Nasdaq
  • Market Cap
  • SEPN 631.0M
  • LEGH 688.3M
  • IPO Year
  • SEPN 2024
  • LEGH 2018
  • Fundamental
  • Price
  • SEPN $5.80
  • LEGH $25.82
  • Analyst Decision
  • SEPN Buy
  • LEGH Buy
  • Analyst Count
  • SEPN 4
  • LEGH 2
  • Target Price
  • SEPN $34.00
  • LEGH $29.00
  • AVG Volume (30 Days)
  • SEPN 857.5K
  • LEGH 102.6K
  • Earning Date
  • SEPN 02-28-2025
  • LEGH 03-14-2025
  • Dividend Yield
  • SEPN N/A
  • LEGH N/A
  • EPS Growth
  • SEPN N/A
  • LEGH N/A
  • EPS
  • SEPN N/A
  • LEGH 2.18
  • Revenue
  • SEPN $981,000.00
  • LEGH $163,718,000.00
  • Revenue This Year
  • SEPN $406.62
  • LEGH N/A
  • Revenue Next Year
  • SEPN N/A
  • LEGH $8.95
  • P/E Ratio
  • SEPN N/A
  • LEGH $11.86
  • Revenue Growth
  • SEPN N/A
  • LEGH N/A
  • 52 Week Low
  • SEPN $4.17
  • LEGH $19.42
  • 52 Week High
  • SEPN $28.99
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • LEGH 46.68
  • Support Level
  • SEPN N/A
  • LEGH $25.77
  • Resistance Level
  • SEPN N/A
  • LEGH $29.15
  • Average True Range (ATR)
  • SEPN 0.00
  • LEGH 1.22
  • MACD
  • SEPN 0.00
  • LEGH -0.11
  • Stochastic Oscillator
  • SEPN 0.00
  • LEGH 29.06

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to customers to facilitate the sale of homes.

Share on Social Networks: